» Articles » PMID: 16921377

TRAF6 is a T Cell-intrinsic Negative Regulator Required for the Maintenance of Immune Homeostasis

Overview
Journal Nat Med
Date 2006 Aug 22
PMID 16921377
Citations 119
Authors
Affiliations
Soon will be listed here.
Abstract

TRAF6 has a key role in the regulation of innate immune responses by mediating signals from both TNF receptor and interleukin-1 receptor/Toll-like receptor superfamilies. Here we show that T cell-specific deletion of TRAF6 unexpectedly results in multiorgan inflammatory disease. TRAF6-deficient T cells exhibit hyperactivation of the phosphatidylinositol 3-kinase (PI3K)-Akt pathway compared with wild-type T cells and, as a result, become resistant to suppression by CD4+ CD25+ regulatory T cells. These data identify a previously unrecognized role for TRAF6 in the maintenance of peripheral tolerance, and suggest the presence of a T cell-intrinsic control mechanism to render responder T cells susceptible to tolerizing signals.

Citing Articles

Investigating the effects of on H3N2-Induced inflammatory and immune responses through network pharmacology, molecular docking, and experimental validation in a mice model.

Chen Y, Chen Z, Wang W, Wang Y, Zhu J, Wang X Heliyon. 2024; 10(8):e29487.

PMID: 38665556 PMC: 11043942. DOI: 10.1016/j.heliyon.2024.e29487.


The OX40-TRAF6 axis promotes CTLA-4 degradation to augment antitumor CD8 T-cell immunity.

Yu J, Cui J, Zhang X, Xu H, Chen Z, Li Y Cell Mol Immunol. 2023; 20(12):1445-1456.

PMID: 37932534 PMC: 10687085. DOI: 10.1038/s41423-023-01093-y.


Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets.

Laletin V, Bernard P, Da Silva C, Guittard G, Nunes J J Immunother Cancer. 2023; 11(5).

PMID: 37217244 PMC: 10231026. DOI: 10.1136/jitc-2022-005845.


TRAF6 controls T cell homeostasis by maintaining the equilibrium of MALT1 scaffolding and protease functions.

ONeill T, Gewies A, Seeholzer T, Krappmann D Front Immunol. 2023; 14:1111398.

PMID: 36761777 PMC: 9902345. DOI: 10.3389/fimmu.2023.1111398.


Metabolic Regulation of T cell Activity: Implications for Metabolic-Based T-cell Therapies for Cancer.

Abdesheikhi J, Sedghy F, Mahmoodi M, Fallah H, Ranjkesh M Iran Biomed J. 2023; 27(1):1-14.

PMID: 36624636 PMC: 9971708. DOI: 10.52547/ibj.3811.